Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR | Market Cap | 804.99B +16.0% |
| Revenue (ttm) | 331.82B +7.3% |
| Net Income | 34.87B -0.1% |
| EPS | 60.04 +0.4% |
| Shares Out | 580.80M |
| PE Ratio | 23.09 |
| Forward PE | 19.06 |
| Dividend | 8.00 (0.58%) |
| Ex-Dividend Date | n/a |
| Volume | 706,607 |
| Average Volume | 1,689,527 |
| Open | 1,392.00 |
| Previous Close | 1,386.00 |
| Day's Range | 1,363.50 - 1,392.00 |
| 52-Week Range | 1,016.10 - 1,394.90 |
| Beta | -0.01 |
| RSI | 65.93 |
| Earnings Date | May 30, 2026 |
About Aurobindo Pharma
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretrovira... [Read more]
Financial Performance
In fiscal year 2025, Aurobindo Pharma's revenue was 317.24 billion, an increase of 9.39% compared to the previous year's 290.02 billion. Earnings were 34.86 billion, an increase of 9.86%.
Financial StatementsNews
Aurobindo Pharma receives USFDA approval for Dextromethorphan Polistirex suspension
Aurobindo Pharma has secured final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dextromethorphan Polistirex Extended-Release Oral Suspension, 30 mg/5 mL (OTC). Thi...
Aurobindo Pharma receives USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL. This product is bioequivale...
HAL, Trent & more: Top stocks on brokers' radar today
Analysts are bullish on Adani Enterprises, HAL, and Trent, citing growth drivers like new energy and engine co-production. Aurobindo Pharma's biologics expansion shows promise but financial gains are ...
Stocks to watch on brokerages today, April 16: Aurobindo Pharma, Adani Enterprises, HAL, ICICI Lombard in focus
Brokerage firms have shared fresh views on several key Indian stocks on April 16, highlighting developments across pharmaceuticals, infrastructure, cement, retail, insurance, NBFCs and defence. Stocks...
Top stocks for trade today, April 16: Aurobindo Pharma, ICICI Lombard, HDB Financial, Tejas Networks, Delhivery, RailTel in focus
Indian markets are expected to see stock-specific action on April 16, with several companies making headlines across sectors including pharma, financials, logistics, and infrastructure. Here are the k...
Aurobindo Pharma subsidiary to invest up to USD 175 million in new manufacturing facility
TheraNym Biologics Private Limited, a subsidiary of Aurobindo Pharma, has announced an expansion of its existing contract manufacturing operations (CMO) agreement with Merck Sharpe & Dohme Singapore T...
Top stocks for trade today, April 8: Aurobindo Pharma, Lupin, Angel One, Infosys, PB Fintech and more
Indian equity markets are expected to react to a mix of company-specific developments and global cues, particularly easing crude oil prices following a temporary ceasefire in West Asia. Here’s a…
Aurobindo Pharma secures USFDA approval for diabetes drug with estimated market size of $514 million
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in vari...
Aurobindo Pharma receives USFDA approval for Dapagliflozin tablets with market size of $10.2 billion
Aurobindo Pharma has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin Tablets, 5 mg and 10 mg. These…
Top stocks for trade today, April 7: Godrej Consumer Products, Kalyan Jewellers, IRFC, Aurobindo Pharma and more
A range of corporate updates across consumption, railways, finance, pharma, and metals is expected to keep several stocks in focus on April 7. Earnings indicators, order wins, regulatory approvals, an...
Aurobindo Pharma's CuraTeQ Biologics announces positive results for omalizumab biosimilar study
CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has announced positive top-line results from its Phase 3 study of BP11, an investigational biosimilar to Xolair® (omal...
Aurobindo Pharma gets board nod for Rs 800 crore share buyback plan
India Business News: Hyderabad: Aurobindo Pharma’s board on Monday approved a Rs 800 crore share proposal to buy back up to 54.23 lakh fully paid-up equity shares of the c.
Pharma sector stocks fall sharply today: Sun Pharma down 4.89%, Aurobindo Pharma falls 4.48%, Biocon drops 4.67%
Indian pharmaceutical stocks declined in early trade on April 2, 2026, with most listed companies showing losses on both BSE and NSE. As of approximately 9:23-9:25 AM IST, the majority…
Aurobindo Pharma to complete 26% stake acquisition in Swarnaakshu Solar by June 2026
Aurobindo Pharma has announced an update regarding its solar power purchase agreement and acquisition of up to a 26% stake in Swarnaakshu Solar Power Private Limited. The company had previously…
Aurobindo Pharma subsidiary CuraTeQ Biologics enters EU biosimilars agreement with STADA
CuraTeQ Biologics Pvt Ltd, a wholly owned subsidiary of Aurobindo Pharma Ltd, has entered into a marketing and distribution agreement with STADA Arzneimittel AG, a leading European healthcare and phar...
Top stocks to buy today: Stock recommendations for March 25, 2026 - check list
Stock market recommendations: Aurobindo Pharma, Infosys, and Larsen & Toubro (L&T) - these are the stocks that Mehul Kothari, DVP - Technical Research at Anand Rathi Shares and Stock Brokers has recom...
Aurobindo Pharma's subsidiary facility classified as 'Voluntary Action Indicated' by US FDA
Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Apitoria Pharma Private Limited, has received a positive classification from the United States Food and Drug Administration (US...
Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42%
The pharmaceutical sector in India showed positive movement on March 20, 2026, during early trading hours. The S&P BSE HEALTHCARE Index stood at 42,149.5, reflecting a gain of 1.1%. This…
Aurobindo Pharma's Eugia Pharma unit classified as OAI by US FDA
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities Limited, has had its Unit-II classified as 'Official Action Indicated' (OAI) by the United States Food and Drug Administration (US FDA). This f...
Aurobindo Pharma faces ₹77.61 crore GST demand and penalty
Aurobindo Pharma has been ordered to pay a GST demand and penalty totalling ₹77.61 crore by the Principal Commissioner of Customs and Central Tax (Appeals I), Hyderabad. The order confirms…
Aurobindo Pharma's Unit-IV receives VAI classification from US FDA
Aurobindo Pharma's Unit-IV, part of APL Healthcare Limited, has been classified as 'Voluntary Action Indicated' (VAI) by the US FDA, marking the closure of its recent inspection. The inspection of…
Top stocks to buy or sell: Stock market recommendations for today - check list
Stock market recommendations: Aurobindo Pharma Ltd, and Bharat Dynamic are the top buy calls by Somil Mehta, Head of Retail Research, Mirae Asset ShareKhan for March 10, 2026. Persistent is a sell cal...
Aurobindo Pharma subsidiary launches Pomalidomide Capsules in US market, targets $3.3 billion opportunity
Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has launched Pomalidomide Capsules in strengths of 1 mg, 2 mg, 3 mg and 4 mg…
Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more
Indian stock markets are expected to track a busy news flow on March 2, with developments across pharmaceuticals, infrastructure, auto...
Aurobindo Pharma subsidiary receives 4 observations after US FDA inspection at Telangana facility
Aurobindo Pharma informed the stock exchanges that the United States Food and Drug Administration (US FDA) has completed an inspection...